SBIR-STTR Award

New Organosilicon Maxillofacial Prosthetic Materials
Award last edited on: 6/2/09

Sponsored Program
SBIR
Awarding Agency
NIH : NIDCR
Total Award Amount
$815,520
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Juey H Lai

Company Information

LAI Laboratories Inc

12101 16th Avenue South
Burnsville, MN 55337
   (952) 882-0717
   jlai@aol.com
   N/A
Location: Single
Congr. District: 02
County: Dakota

Phase I

Contract Number: 1R43DE011076-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1994
Phase I Amount
$68,272
This research will develop an improved maxil of acial prosthetic material based on a new organosilicon polymer and monomer. The siloxane polymer possesses reactive end groups and will undergo thermal-crosslinking with a siloxane monomer which possesses similar end groups. The indentation hardness, tensile strength, percent elongation, the elongation at break, and tear strength of the material will be determined and compared with those of commercial silicone maxillofacial prosthetic material. The new materials are expected to have strong tear strength, good bonding to the adhesive, good miscibility with the pigments and colorants, and require processing temperature below 100C.Awardee's statement of the potential commercial applications of the research:Potential commercial applications of the research is the development of an improved maxillofacial prosthetic material which have strong tear strength, good bonding to the adhesives, good miscibility with the pigments and colorants, and does not require lSigh processing temperature.National Institute of Dental Research (NIDR)

Phase II

Contract Number: 2R44DE011076-02A1
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
1996
(last award dollars: 1997)
Phase II Amount
$747,248

This research aims to develop improved maxillofacial prosthetic materials based on a unique methacrylic siloxane polymer. In Phase I, the formulations of the maxillofacial prosthetic materials were studied as functions of cure temperature, initiator concentration, filler concentration, and the nature and the concentration of the crosslinkers. The materials were evaluated in terms of hardness, ultimate elongation, tensile strength, tear strength and bonding strength to adhesives. The dispersibility of pigments with the maxillofacial materials was studied. Color stability of the materials with and without pigments and uv stabilizers was investigated. In Phase II research, the performance of the maxillofacial materials will be improved by further optimizing the material formulations. The optimization will be achieved by: 1. Broadening the selection of the crosslinking agents, 2. Determination of the mechanical properties, hardness, ultimate elongation, tensile strength, tear strength and adhesive bonding strength, 3. Optimization of the maxillofacial material formulations including the determination of optimum cure temperature and time, 4. Development of both intrinsic and extrinsic coloration processes, 5. Evaluating and improving the color stability, 6. Transfer of material technology to the University of Minnesota School of Dentistry for fabrication of clinical prostheses, and 7. Fabrication, application, and evaluation of the clinical prostheses. PROPOSED COMMERCIAL APPLICATION: Development of high performance maxillofacial prosthetic materials which cure at low temperatures (less than 100 degrees Celcius), have high tear strength, strong bonding to adhesives, are capable of accepting and retaining intrinsic and extrinsic coloration, have improved color stability, and are suitable for clinical applications